Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Show: All - Companies - Funds
Results 1 - 15 of about 8 companies and 7 funds for JOSEPH QUINN�
Company Exchange Symbol Last price Quote change Market cap
LKQ Corporation NASDAQ LKQ 33.91 +0.07 (0.21%) 10.47B
LKQ Corporation (LKQ) is a global distributor of vehicle products, including replacement parts, components and systems used in the repair and maintenance of ...
Executive:
Joseph M. Holsten
Tidewater Inc. NYSE TDW 4.47 0.00 (0.00%) 215.70M
Tidewater Inc. provides offshore service vessels and marine support services. The Company operates through four segments: Americas, Asia/Pacific, ...
Executive:
Joseph M. Bennett
OMNOVA Solutions Inc. NYSE OMN 9.76 0.00 (0.00%) 446.67M
OMNOVA Solutions Inc. (OMNOVA) is a provider of emulsion polymers, specialty chemicals and engineered surfaces for commercial, industrial and residential ...
Executive:
Joseph M.
National Presto Industries Inc. NYSE NPK 91.37 0.00 (0.00%) 632.91M
National Presto Industries, Inc. (National Presto) manufactures pressure cookers and canners, ammunition and private label adult incontinence products.
Executive:
Joseph G. Stienessen CPA
Endologix, Inc. NASDAQ ELGX 14.14 +0.04 (0.28%) 1.18B
Endologix, Inc. is engaged in developing, manufacturing, marketing and selling medical devices for the treatment of aortic disorders.
Executive:
Joseph A. DeJohn
GSE Systems, Inc. NYSEMKT GVP 2.39 -0.01 (-0.42%) 42.39M
GSE Systems, Inc. (GSE) is a performance improvement company. The Company operates through two segments: Performance Improvement Solutions, ...
Executive:
Joseph W. Lewis
CSW Industrials Inc NASDAQ CSWI 34.46 +0.06 (0.17%) 547.38M
CSW Industrials, Inc. (CSWI) is a diversified industrial growth company. The Company operates through three segments: Industrial Products; Coatings, ...
Executive:
Joseph B. Armes
Aeglea Bio Therapeutics Inc NASDAQ AGLE 4.69 -0.01 (-0.21%) 65.55M
Aeglea BioTherapeutics, Inc. is a biotechnology company. The Company is engaged in the development of enzyme-based therapeutics in the field of amino acid ...
Executive:
Joseph E. Tyler
Mutual Fund Symbol Nav Nav change
MassMutual Select Large Cap Value Fund Class A MMLAX 7.19 +0.01 (0.14%)
The investment seeks both capital growth and income. Under normal circumstances, the fund invests at least 80% of its net assets (plus the amount of any ...
Executive:
Joseph R. Huber
MassMutual Select Large Cap Value Fund Class R5 MLVSX 7.23 +0.01 (0.14%)
The investment seeks both capital growth and income. Under normal circumstances, the fund invests at least 80% of its net assets (plus the amount of any ...
Executive:
Joseph R. Huber
MassMutual Select Large Cap Value Fund Service Class MMLYX 7.25 +0.02 (0.28%)
The investment seeks both capital growth and income. Under normal circumstances, the fund invests at least 80% of its net assets (plus the amount of any ...
Executive:
Joseph R. Huber
MassMutual Select Large Cap Value Fund Class R3 MLVNX 7.03 +0.01 (0.14%)
The investment seeks both capital growth and income. Under normal circumstances, the fund invests at least 80% of its net assets (plus the amount of any ...
Executive:
Joseph R. Huber
MassMutual Select Large Cap Value Fund Administrative Class MLVLX 7.21 +0.02 (0.28%)
The investment seeks both capital growth and income. Under normal circumstances, the fund invests at least 80% of its net assets (plus the amount of any ...
Executive:
Joseph R. Huber
MassMutual Select Large Cap Value Fund Class I MLVZX 7.22 +0.02 (0.28%)
The investment seeks both capital growth and income. Under normal circumstances, the fund invests at least 80% of its net assets (plus the amount of any ...
Executive:
Joseph R. Huber
MassMutual Select Large Cap Value Fund Class R4 MLVFX 7.16 +0.02 (0.28%)
The investment seeks both capital growth and income. Under normal circumstances, the fund invests at least 80% of its net assets (plus the amount of any ...
Executive:
Joseph R. Huber